Trillium Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,002
| Closed | -$255K | – | 235 |
|
|
2022
Q4 | $255K | Sell |
2,002
-267
| -12% | -$31K | 0.01% | 224 |
|
|
2022
Q3 | $237K | Sell |
2,269
-487
| -18% | -$53.4K | 0.01% | 217 |
|
|
2022
Q2 | $290K | Sell |
2,756
-1,095
| -28% | -$130K | 0.01% | 214 |
|
|
2022
Q1 | $492K | Buy |
3,851
+907
| +31% | +$109K | 0.01% | 209 |
|
|
2021
Q4 | $363K | Buy |
2,944
+86
| +3% | +$11.3K | 0.01% | 227 |
|
|
2021
Q3 | $406K | Sell |
2,858
-6
| -0.2% | -$883 | 0.01% | 213 |
|
|
2021
Q2 | $447K | Sell |
2,864
-481
| -14% | -$77.9K | 0.01% | 211 |
|
|
2021
Q1 | $520K | Sell |
3,345
-739
| -18% | -$114K | 0.02% | 201 |
|
|
2020
Q4 | $611K | Buy |
4,084
+573
| +16% | +$80.9K | 0.02% | 197 |
|
|
2020
Q3 | $464K | Sell |
3,511
-306
| -8% | -$40K | 0.02% | 192 |
|
|
2020
Q2 | $442K | Sell |
3,817
-391
| -9% | -$45.1K | 0.02% | 200 |
|
|
2020
Q1 | $413K | Buy |
4,208
+87
| +2% | +$11.4K | 0.02% | 202 |
|
|
2019
Q4 | $599K | Sell |
4,121
-507
| -11% | -$70K | 0.03% | 199 |
|
|
2019
Q3 | $617K | Buy |
4,628
+18
| +0.4% | +$2.33K | 0.03% | 206 |
|
|
2019
Q2 | $527K | Sell |
4,610
-296
| -6% | -$34.7K | 0.03% | 195 |
|
|
2019
Q1 | $608K | Sell |
4,906
-621
| -11% | -$70.6K | 0.03% | 199 |
|
|
2018
Q4 | $557K | Sell |
5,527
-3,403
| -38% | -$383K | 0.03% | 192 |
|
|
2018
Q3 | $1.14M | Sell |
8,930
-55,073
| -86% | -$6.55M | 0.06% | 187 |
|
|
2018
Q2 | $6.92M | Sell |
64,003
-32,694
| -34% | -$3.56M | 0.37% | 93 |
|
|
2018
Q1 | $10.2M | Sell |
96,697
-598
| -0.6% | -$69.4K | 0.56% | 66 |
|
|
2017
Q4 | $11.4M | Sell |
97,295
-979
| -1% | -$111K | 0.63% | 66 |
|
|
2017
Q3 | $11.2M | Buy |
98,274
+52
| +0.1% | +$6K | 0.64% | 63 |
|
|
2017
Q2 | $12.2M | Sell |
98,222
-9,394
| -9% | -$1.11M | 0.73% | 56 |
|
|
2017
Q1 | $12.8M | Sell |
107,616
-11,427
| -10% | -$1.3M | 0.82% | 48 |
|
|
2016
Q4 | $11.9M | Buy |
119,043
+5,201
| +5% | +$557K | 0.78% | 52 |
|
|
2016
Q3 | $14.4M | Sell |
113,842
-30,708
| -21% | -$3.79M | 0.92% | 34 |
|
|
2016
Q2 | $16.9M | Buy |
144,550
+11,078
| +8% | +$1.25M | 1.11% | 27 |
|
|
2016
Q1 | $13.8M | Buy |
133,472
+5,705
| +4% | +$552K | 0.92% | 38 |
|
|
2015
Q4 | $12.7M | Sell |
127,767
-206
| -0.2% | -$20.2K | 0.86% | 44 |
|
|
2015
Q3 | $11.7M | Buy |
127,973
+5,211
| +4% | +$522K | 0.82% | 42 |
|
|
2015
Q2 | $13M | Buy |
122,762
+3,916
| +3% | +$433K | 0.83% | 45 |
|
|
2015
Q1 | $13.6M | Buy |
118,846
+49,308
| +71% | +$5.63M | 0.88% | 40 |
|
|
2014
Q4 | $7.66M | Sell |
69,538
-1,998
| -3% | -$211K | 0.52% | 80 |
|
|
2014
Q3 | $6.98M | Buy |
71,536
+134
| +0.2% | +$13.2K | 0.6% | 66 |
|
|
2014
Q2 | $7.2M | Buy |
71,402
+9,944
| +16% | +$970K | 0.62% | 67 |
|
|
2014
Q1 | $5.64M | Buy |
61,458
+2,311
| +4% | +$213K | 0.53% | 75 |
|
|
2013
Q4 | $5.35M | Buy |
59,147
+1,718
| +3% | +$149K | 0.53% | 86 |
|
|
2013
Q3 | $4.58M | Buy |
57,429
+3,450
| +6% | +$272K | 0.51% | 87 |
|
|
2013
Q2 | $3.93M | Buy |
+53,979
| New | +$4.04M | 0.48% | 81 |
|
Other funds holding ZBH
Trillium Asset Management's ZBH Position: Q1 2023 in Review
Trillium Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 2,002 shares — an estimated $255K sold.
Trillium Asset Management first reported a position in ZBH in Q2 2013 and held it in 39 quarters. The position peaked at $16.9M in Q2 2016. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.
- Trillium Asset Management reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
- Trillium Asset Management sold 2,002 Zimmer Biomet shares in Q1 2023, an estimated $255K.
- Trillium Asset Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 39 quarters.
- Trillium Asset Management's Zimmer Biomet position peaked at $16.9M in Q2 2016.
- 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.
Based on Trillium Asset Management's 13F filing for Q1 2023, filed 9 May 2023.